O. Finance

发表

SSR240612 [(2R)-2-[((3R)-3-(1,3-Benzodioxol-5-yl)-3-{[(6-methoxy-2-naphthyl)sulfonyl]amino}propanoyl)amino]-3-(4-{[2R,6S)-2,6-dimethylpiperidinyl]methyl}phenyl)-N-isopropyl-N-methylpropanamide Hydrochloride], a New Nonpeptide Antagonist of the Bradykinin B1 Receptor: Biochemical and Pharmacological

P. Soubrié, M. Poncelet, J. Maruani, 2004, Journal of Pharmacology and Experimental Therapeutics.

Hemodynamic and antiadrenergic effects of dronedarone and amiodarone in animals with a healed myocardial infarction.

D. Nisato, P. Gautier, G. Pastor, 2000, Journal of cardiovascular pharmacology.

Biochemical and Pharmacological Characterization of 2-(9-(2-Piperidinoethoxy)-4-oxo-4H-pyrido[1,2-a]pyrimidin-2-yloxymethyl)-4-(1-methylethyl)-6-methoxy-1,2-benzisothiazol-3(2H)-one-1,1-dioxide (SSR69071), a Novel, Orally Active Elastase Inhibitor

T. Szabó, Márton Varga, P. Arányi, 2003, Journal of Pharmacology and Experimental Therapeutics.

Cannabinoid CB2 receptor activation prevents bronchoconstriction and airway oedema in a model of gastro-oesophageal reflux

Hong-Zhuan Chen, E. Naline, M. Rinaldi-Carmona, 2007 .

Pitolisant for the treatment of cataplexy in adults with narcolepsy

G. Meskill, U. Kallweit, X. Ligneau, 2021, Expert Opinion on Orphan Drugs.

Drotaverine interacts with the L-type Ca(2+) channel in pregnant rat uterine membranes.

P. Arányi, Z. Tömösközi, O. Finance, 2002, European journal of pharmacology.

carboxamide ] , a New Potent and Selective Antagonist of the CB 1 Cannabinoid Receptor : Biochemical and Pharmacological Characterization

P. Soubrié, M. Poncelet, G. Fur, 2004 .

SR147778 [5-(4-Bromophenyl)-1-(2,4-dichlorophenyl)-4-ethyl-N-(1-piperidinyl)-1H-pyrazole-3-carboxamide], a New Potent and Selective Antagonist of the CB1 Cannabinoid Receptor: Biochemical and Pharmacological Characterization

P. Soubrié, M. Poncelet, J. Maruani, 2004, Journal of Pharmacology and Experimental Therapeutics.

Cannabinoid CB(2) receptor activation prevents bronchoconstriction and airway oedema in a model of gastro-oesophageal reflux.

Hong-Zhuan Chen, E. Naline, M. Rinaldi-Carmona, 2007, European journal of pharmacology.

Pitolisant, a wake‐promoting agent devoid of psychostimulant properties: Preclinical comparison with amphetamine, modafinil, and solriamfetol

J. Schwartz, S. Krief, J. Lecomte, 2021, Pharmacology research & perspectives.

2 R , 6 S )-2 , 6-dimethylpiperidinyl ] methyl } phenyl )-N-isopropyl-N-methylpropanamide Hydrochloride ] , a New Nonpeptide Antagonist of the Bradykinin B 1 Receptor : Biochemical and Pharmacological Characterization

P. Soubrié, M. Poncelet, G. Fur, 2004 .

Rational design of a novel peripherally-restricted, orally active CB(1) cannabinoid antagonist containing a 2,3-diarylpyrrole motif.

M. Rinaldi-Carmona, F. Barth, C. Congy, 2010, Bioorganic & medicinal chemistry letters.

Effects of a new amiodarone-like agent, SR 33589, in comparison to amiodarone, D,L-sotalol, and lignocaine, on ischemia-induced ventricular arrhythmias in anesthetized pigs.

P. Chatelain, A. Manning, O. Finance, 1995, Journal of cardiovascular pharmacology.